Nota Informativa MUH (FV), 01/2013 – Noticias del Centro de Farmacovigilancia de Canarias

Nota Informativa MUH (FV), 01/2013

Fingolimod (Gilenya®): se amplían las recomendaciones de monitorización

Noticias del Centro de Farmacovigilancia de Canarias

Copia y pega esta URL en tu sitio WordPress para incrustarlo

<blockquote class="wp-embedded-content"><a href="https://www.farmacovigilanciacanarias.org/noticias/2013/01/14/fingolimod-gilenya-se-amplian-las-recomendaciones-de-monitorizacion/">Nota Informativa MUH (FV), 01/2013</a></blockquote>
<script type='text/javascript'>
<!--//--><![CDATA[//><!--
		!function(d,l){"use strict";var e=!1,n=!1;if(l.querySelector)if(d.addEventListener)e=!0;if(d.wp=d.wp||{},!d.wp.receiveEmbedMessage)if(d.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!/[^a-zA-Z0-9]/.test(t.secret)){for(var r,i,a,s=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),n=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),o=new RegExp("^https?:$","i"),c=0;c<n.length;c++)n[c].style.display="none";for(c=0;c<s.length;c++)if(r=s[c],e.source===r.contentWindow){if(r.removeAttribute("style"),"height"===t.message){if(1e3<(a=parseInt(t.value,10)))a=1e3;else if(~~a<200)a=200;r.height=a}if("link"===t.message)if(i=l.createElement("a"),a=l.createElement("a"),i.href=r.getAttribute("src"),a.href=t.value,o.test(a.protocol))if(a.host===i.host)if(l.activeElement===r)d.top.location.href=t.value}}},e)d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",t,!1),d.addEventListener("load",t,!1);function t(){if(!n){n=!0;for(var e,t,r=-1!==navigator.appVersion.indexOf("MSIE 10"),i=!!navigator.userAgent.match(/Trident.*rv:11\./),a=l.querySelectorAll("iframe.wp-embedded-content"),s=0;s<a.length;s++){if(!(e=a[s]).getAttribute("data-secret"))t=Math.random().toString(36).substr(2,10),e.src+="#?secret="+t,e.setAttribute("data-secret",t);if(r||i)(t=e.cloneNode(!0)).removeAttribute("security"),e.parentNode.replaceChild(t,e)}}}}(window,document);
//--><!]]>
</script><iframe sandbox="allow-scripts" security="restricted" src="https://www.farmacovigilanciacanarias.org/noticias/2013/01/14/fingolimod-gilenya-se-amplian-las-recomendaciones-de-monitorizacion/embed/" width="600" height="400" title="&#171;Nota Informativa MUH (FV), 01/2013&#187; &#8212; Noticias del Centro de Farmacovigilancia de Canarias" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe>

Copia y pega este código en tu sitio para incrustarlo